REG - Craneware plc - Dividend Currency Election

CranewareAnnouncement

25/11/2022 14:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20221125:nRSY6733Ha&default-theme=true

RNS Number : 6733H  Craneware plc  25 November 2022

Craneware plc

("Craneware" or the "Company")

Dividend Currency Election

25 November 2022 - Craneware plc (AIM: CRW.L), the market leader in Value
Cycle software solutions for the US healthcare market, today gives further
information regarding its final dividend announced on 20 September 2022.

For those shareholders who have previously registered to receive their
dividend in US dollars under the Company's Dividend Currency Election, the
dividend will be paid at an exchange rate of $1.19.

 

For further information, please contact:

 Craneware plc                                               +44 (0)131 550 3100
 Keith Neilson, CEO
 Craig Preston, CFO

 Alma (Financial PR)                                         +44 (0)20 3405 0205
 Caroline Forde, Hilary Buchanan, Joe Pederzolli             craneware@almapr.co.uk (mailto:craneware@almapr.co.uk)

 Peel Hunt (NOMAD and Joint Broker)                          +44 (0)20 7418 8900
 Dan Webster, Andrew Clark

 Investec Bank PLC (Joint Broker)                            +44 (0)20 7597 5970
 Patrick Robb, Henry Reast, Sebastian Lawrence
 ( )
 Berenberg (Joint Broker)                                    +44 (0)20 3207 7800
 Mark Whitmore, Richard Andrews, Alix Mecklenburg-Solodkoff

 

 

About Craneware

 

We at The Craneware Group of companies, including our latest additions Sentry
Data Systems and Agilum Healthcare Intelligence, passionately believe we can
impact healthcare profoundly by delivering the insights healthcare
organisations need to also transform the business of healthcare. Our shared
vision is to be the operational and financial partner for US healthcare
providers.

 

Our combined suite of applications and industry-leading team of experts help
our customers contextualise operational, financial, and clinical data,
providing insights that clearly demonstrate what great looks like. These value
cycle insights deliver revenue integrity and 340B compliance, as well as
margin and operational intelligence - something no other single partner can
provide.

 

Together, approximately 40% of registered US hospitals are now our customers,
including more than 12,000 US hospitals, health systems and affiliated retail
pharmacies and clinics. Our customers are operating with a financial impact of
nearly half a trillion dollars. We have data sets from customers covering more
than 150 million unique patients encounters.

 

Learn more at www.thecranewaregroup.com (http://www.thecranewaregroup.com/)

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DIVEALFSAFEAFFA